Senior insider sale
Chief Executive Officer at APOGEE THERAPEUTICS, INC. — senior position signals high conviction
$8.10M
100K shares
What this filing means
HENDERSON MICHAEL THOMAS plans to sell 100K shares of APOGEE THERAPEUTICS, INC. valued at approximately $8.10M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/13/2026ACC: 0001949846-26-000273
DirectorOfficer· Chief Executive Officer
Since Feb 2026
100K
Shares to sell
$8.10M
Approx. market value
60K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
RSU VESTING PER FOLLOWING DATES: 10/02/23 thru 1/2/24
NA
10/2/2023
60KTotal acquired60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/2/2023 | RSU VESTING PER FOLLOWING DATES: 10/02/23 thru 1/2/24 NA | 60K | — |
| Total | 60K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
20K
Market value
$1.65M
4/8/2026
—Completed
Units to sell
20K
Market value
$1.50M
3/11/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
60K
Market value
$4.95M
5/13/2026
Total
Units
100K
Value
$8.10M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/8/2026 | 20K | $1.65M | — | Completed |
3/11/2026 | 20K | $1.50M | — | Completed |
| Planned — Approximate Date | ||||
5/13/2026 | 60K | $4.95M | NASDAQ | Planned |
| Total | 100K | $8.10M | ||